DS
GRTS

David Shaw’s Gritstone bio, Inc. Common Stock GRTS Stock Holding History

David Shaw’s Portfolio GRTS Stock Details GRTS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-10,273
Closed -$42K – 5880
2022
Q1 		$42K Sell
10,273
-337,638
-97% -$1.79M ﹤0.01% 5183
2021
Q4 		$4.47M Sell
347,911
-971,882
-74% -$10.8M ﹤0.01% 2502
2021
Q3 		$14.3M Buy
1,319,793
+65,073
+5% +$592K 0.01% 1244
2021
Q2 		$11.5M Buy
1,254,720
+714,922
+132% +$6.61M 0.01% 1380
2021
Q1 		$5.09M Buy
539,798
+333,436
+162% +$4.59M ﹤0.01% 1830
2020
Q4 		$813K Buy
206,362
+27,195
+15% +$82.2K ﹤0.01% 3159
2020
Q3 		$475K Buy
+179,167
New +$665K ﹤0.01% 3256
2019
Q1 		– Sell
-10,130
Closed -$157K – 3998
2018
Q4 		$157K Buy
+10,130
New +$193K ﹤0.01% 3589

Other funds holding GRTS

RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
VVM
Versant Venture Management San Francisco, California $163M AUM 240.43% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.56% 1-Year Est. Return

David Shaw's GRTS Position: Q2 2022 in Review

David Shaw sold out of Gritstone bio, Inc. Common Stock (GRTS) in Q2 2022, closing a stake of 10,273 shares — an estimated $42K sold.

David Shaw first reported a position in GRTS in Q4 2018 and held it in 8 quarters. The position peaked at $14.3M in Q3 2021. 87 funds tracked by Wall St. Rank hold GRTS as of Q2 2022.

  • David Shaw reported no remaining Gritstone bio, Inc. Common Stock position as of Q2 2022 after selling out during the quarter.
  • David Shaw sold 10,273 Gritstone bio, Inc. Common Stock shares in Q2 2022, an estimated $42K.
  • David Shaw first reported a position in Gritstone bio, Inc. Common Stock in Q4 2018 and held it in 8 quarters.
  • David Shaw's Gritstone bio, Inc. Common Stock position peaked at $14.3M in Q3 2021.
  • 87 funds tracked by Wall St. Rank held Gritstone bio, Inc. Common Stock as of Q2 2022.

Based on D.E. Shaw & Co's 13F filing for Q2 2022, filed 15 Aug 2022.